Cresco assisted Fibricheck in the negotiation of its partnership with Fitbit for integration of the FibriCheck app in Fitbit Devices.
FibriCheck’s mission is to make healthcare widely available, affordable and unlinked to time and location. Fibricheck targets the prevention of possibly life-threatening and disabling strokes by enabling early detection of heart rhythm disorders, with a main focus on atrial fibrillation (Afib). Fibricheck makes the detection of heart rhythm disorders possible with just a smartphone or smartwatch using the clinically validated PPG technology.
David Dessers and Olivier Van Raemdonck assisted Fibricheck in this transaction.
More information on this transaction can be found in De Tijd.